Marathon Nextgen [MARATHON] vs Kolte-Patil [KOLTEPATIL] Detailed Stock Comparison

Marathon Nextgen
NSE
Loading...

Kolte-Patil
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Marathon Nextgen wins in 11 metrics, Kolte-Patil wins in 8 metrics, with 0 ties. Marathon Nextgen appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Marathon Nextgen | Kolte-Patil | Better |
---|---|---|---|
P/E Ratio (TTM) | 15.12 | 42.06 | Marathon Nextgen |
Price-to-Book Ratio | 2.72 | 4.22 | Marathon Nextgen |
Debt-to-Equity Ratio | 46.60 | 136.03 | Marathon Nextgen |
PEG Ratio | 0.24 | -0.11 | Kolte-Patil |
EV/EBITDA | 31.51 | 33.87 | Marathon Nextgen |
Profit Margin (TTM) | 37.49% | 5.71% | Marathon Nextgen |
Operating Margin (TTM) | 21.62% | -36.63% | Marathon Nextgen |
EBITDA Margin (TTM) | 21.62% | N/A | N/A |
Return on Equity | 15.51% | 12.73% | Marathon Nextgen |
Return on Assets (TTM) | 8.89% | 2.01% | Marathon Nextgen |
Free Cash Flow (TTM) | $-286.53M | $2.24B | Kolte-Patil |
Dividend Yield | 0.17% | 0.89% | Kolte-Patil |
1-Year Return | 8.66% | 6.33% | Marathon Nextgen |
Price-to-Sales Ratio (TTM) | 7.61 | 2.80 | Kolte-Patil |
Enterprise Value | $48.08B | $42.04B | Marathon Nextgen |
EV/Revenue Ratio | 8.60 | 2.88 | Kolte-Patil |
Gross Profit Margin (TTM) | 34.21% | 34.59% | Kolte-Patil |
Revenue per Share (TTM) | $109 | $191 | Kolte-Patil |
Earnings per Share (Diluted) | $41.67 | $10.96 | Marathon Nextgen |
Beta (Stock Volatility) | 0.99 | 0.18 | Kolte-Patil |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Marathon Nextgen vs Kolte-Patil Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Marathon Nextgen | -0.60% | -1.89% | -3.75% | 30.67% | 61.02% | 5.72% |
Kolte-Patil | -0.42% | 12.13% | 12.63% | 15.34% | 87.10% | 31.30% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Marathon Nextgen | 8.66% | 143.57% | 1,026.44% | 409.84% | 409.84% | 409.84% |
Kolte-Patil | 6.33% | 48.28% | 174.10% | 200.03% | 652.01% | 114.91% |
Performance & Financial Health Analysis: Marathon Nextgen vs Kolte-Patil
Metric | MARATHON | KOLTEPATIL |
---|---|---|
Market Information | ||
Market Cap | ₹42.51B | ₹40.89B |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 112,530 | 227,106 |
90 Day Avg. Volume | 180,004 | 185,857 |
Last Close | ₹634.75 | ₹467.75 |
52 Week Range | ₹352.05 - ₹769.45 | ₹239.00 - ₹497.55 |
% from 52W High | -17.51% | -5.99% |
All-Time High | ₹769.45 (Jul 17, 2025) | ₹585.00 (Jan 08, 2024) |
% from All-Time High | -17.51% | -20.04% |
Growth Metrics | ||
Quarterly Revenue Growth | -0.13% | -0.76% |
Quarterly Earnings Growth | 0.62% | -0.76% |
Financial Health | ||
Profit Margin (TTM) | 0.37% | 0.06% |
Operating Margin (TTM) | 0.22% | -0.37% |
Return on Equity (TTM) | 0.16% | 0.13% |
Debt to Equity (MRQ) | 46.60 | 136.03 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹231.79 | ₹109.22 |
Cash per Share (MRQ) | ₹2.69 | ₹62.51 |
Operating Cash Flow (TTM) | ₹1.22B | ₹3.35B |
Levered Free Cash Flow (TTM) | ₹1.87B | ₹1.07B |
Dividends | ||
Last 12-Month Dividend Yield | 0.17% | 0.89% |
Last 12-Month Dividend | ₹1.00 | ₹4.00 |
Valuation & Enterprise Metrics Analysis: Marathon Nextgen vs Kolte-Patil
Metric | MARATHON | KOLTEPATIL |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 15.12 | 42.06 |
Forward P/E | N/A | 26.80 |
PEG Ratio | 0.24 | -0.11 |
Price to Sales (TTM) | 7.61 | 2.80 |
Price to Book (MRQ) | 2.72 | 4.22 |
Market Capitalization | ||
Market Capitalization | ₹42.51B | ₹40.89B |
Enterprise Value | ₹48.08B | ₹42.04B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 8.60 | 2.88 |
Enterprise to EBITDA | 31.51 | 33.87 |
Risk & Other Metrics | ||
Beta | 0.99 | 0.18 |
Book Value per Share (MRQ) | ₹231.79 | ₹109.22 |
Financial Statements Comparison: Marathon Nextgen vs Kolte-Patil
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | MARATHON | KOLTEPATIL |
---|---|---|
Revenue/Sales | ₹1.49B | ₹7.19B |
Cost of Goods Sold | ₹923.55M | ₹5.39B |
Gross Profit | ₹562.28M | ₹1.80B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹407.45M | ₹1.02B |
EBITDA | ₹807.21M | ₹1.12B |
Pre-Tax Income | ₹619.99M | ₹1.01B |
Income Tax | ₹138.37M | ₹349.60M |
Net Income (Profit) | ₹542.28M | ₹662.80M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | MARATHON | KOLTEPATIL |
---|---|---|
Cash & Equivalents | ₹181.41M | ₹1.80B |
Total Current Assets | ₹10.93B | ₹45.48B |
Total Current Liabilities | ₹5.08B | ₹44.29B |
Long-Term Debt | ₹3.78B | ₹244.20M |
Total Shareholders Equity | ₹12.03B | ₹8.37B |
Retained Earnings | N/A | N/A |
Property, Plant & Equipment | N/A | ₹1.50B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | MARATHON | KOLTEPATIL |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | MARATHON | KOLTEPATIL |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 112,530 | 227,106 |
Average Daily Volume (90 Day) | 180,004 | 185,857 |
Shares Outstanding | 51.21M | 76.00M |
Float Shares | 26.79M | 20.32M |
% Held by Insiders | 0.09% | 0.61% |
% Held by Institutions | 0.11% | 0.08% |
Dividend Analysis & Yield Comparison: Marathon Nextgen vs Kolte-Patil
Metric | MARATHON | KOLTEPATIL |
---|---|---|
Last 12-Month Dividend | ₹1.00 | ₹4.00 |
Last 12-Month Dividend Yield | 0.17% | 0.89% |
3-Year Avg Annual Dividend | ₹0.83 | ₹3.33 |
3-Year Avg Dividend Yield | 0.20% | 0.91% |
3-Year Total Dividends | ₹2.50 | ₹10.00 |
Ex-Dividend Date | Sep 17, 2024 | Aug 09, 2024 |